Table 2.
Patient Characteristics at Cohort Entry
| Characteristic | Total population (n=8657) | Had advanced heart failurea (n=847) | Did not have advanced heart failure (n=7810) |
|---|---|---|---|
| Age (y), mean ± SD | 74.1±15.0 | 75.4±14.2 | 73.9±15.0 |
| Female, n (%) | 4309 (49.8) | 381 (45.0) | 3928 (50.3) |
| White, n (%) | 7887 (91.1) | 739 (87.2) | 7148 (91.5) |
| Hispanic, n (%) | 198 (2.3) | 13 (1.5) | 185 (2.4) |
| Renal disease, n (%) | 1673 (19.3) | 250 (29.5) | 1423 (18.2) |
| Chronic obstructive pulmonary disease, n (%) | 2540 (29.3) | 324 (38.3) | 2216 (28.4) |
| Diabetes, n (%) | 2644 (30.5) | 330 (39.0) | 2314 (29.6) |
| Peripheral vascular disease, n (%) | 2250 (26.0) | 276 (32.6) | 1974 (25.3) |
| Cerebrovascular disease, n (%) | 1189 (13.7) | 147 (17.4) | 1042 (13.3) |
| Charlson comorbidity index, median (interquartile range) | 3 (2, 4) | 3 (2, 5) | 3 (1, 4) |
| Body mass index (kg/m2), median (interquartile range) | 28.6 (24.5, 33.8) | 29.0 (24.7, 34.2) | 28.5 (24.5, 33.8) |
a
Had advanced heart failure in the study period but not necessarily at cohort entry.